Knight Therapeutics | GUD - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
Akebia Therapeutics 342.13M 7.53M 2026-09
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aurora Cannabis CAD 464K 234K 2026-06
Avita Medical AUD 1.25M 100K 2025-06
Canopy Growth CAD 12.68M 364K 2026-06
Cronos Group USD 0 7K 2024-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
IQVIA Holdings USD 203M 6M 2026-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Moderna USD 10.96B 527M 2026-06
Omeros USD 4.05M 5.16M 2024-09
Organigram Holdings CAD 179K 127K 2025-03
Organon & Co USD 106M 2M 2026-09
Revvity USD 20.81M 2.18M 2026-09
Tectonic Therapeutic USD 237.03M 9.54M 2026-06
Tilray USD 6.7M 2.73M 2025-06
Viatris USD 120.7M 600K 2026-06
Xeris Pharmaceuticals USD 6.95M 63K 2026-06